Catheter developer CardioVascular Dynamics of Irvine, CA, hassigned a co-distribution deal with cardiology device manufacturerMedtronic of Minneapolis. Medtronic will buy a minimum numberof CVD angioplasty catheters for global distribution for up tothree
Catheter developer CardioVascular Dynamics of Irvine, CA, has
signed a co-distribution deal with cardiology device manufacturer
Medtronic of Minneapolis. Medtronic will buy a minimum number
of CVD angioplasty catheters for global distribution for up to
three years. The catheters covered by the agreement use CVD's
focus technology, which concentrates the device's expansion energy
on a specific area of the balloon. CVD will continue to sell focus-technology-based
catheters through its own direct and indirect sales network.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.